ACROBiosystems Launches ACRO AIx and Rapid Antibody Validation Service
ACROBiosystems announced in a press release the launch of ACRO AIx and its CHO-Direct Rapid High Throughput Affinity Validation Service. CHO-Direct can provide antibody affinity data within four days of sequence submission, using a CHO cell system to test candidates generated through computational drug discovery.
ACRO AIx combines standardized products, experimental tools, validation modules and data connections for biopharmaceutical research. Its tools include CHO cell lines, culture media and transfection reagents, while planned APIs will connect inventory, product specifications, quality reports and order status with AI tools and research workflows.
The company says its validation capabilities cover more than 5,000 target proteins and over 300 membrane protein targets. It also introduced GlobalLifeShip, a service for international transportation, overseas warehousing and final delivery.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Nov 12 EU project ResPECT to build generative AI assistant for cancer and depression care Nov 12 Marpai says AI agents handle routine claim inquiries as revenue returns to growth Nov 12 NHS England deletes claim that 137 hospital trusts benefit from Palantir's AI data platform Nov 12 Trial finds ChatGPT helped oncologists record more chemotherapy side effects, but patients did no better Nov 12 Lapsi Health adds emergency doctors' guidance to its Keikku clinical AILife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Market report
2025 Generative AI in Professional Services Report
Thomson Reuters
This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.
Read moreYou may also like
Asteromorph Opens Wet Lab for AI Biology Research
ACL Digital Launches AgentixCare for Healthcare Operations
OpenAI acquires Orchestra Bio to bring AI agents into drug development
ALLOX Raises $10.5 Million for AI Drug Discovery Platform
Illumina Adds Three Research Tools to BioInsight Platform
Daily AI Brief: the AI news that matters, in your inbox.